← All companies

RTSN

Retension Pharmaceuticals, Inc.

RTSN Nasdaq Pharmaceutical Preparations EDGAR ↗

$15.50

+0.50 +3.33%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$9.66 – $18.64

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Oct 13, 2026

Other filings

SCHEDULE 13G Oct 16, 2026

SCHEDULE 13G Oct 16, 2026

SCHEDULE 13G Oct 15, 2026

SCHEDULE 13D Oct 14, 2026

4 OWNERSHIP DOCUMENT Oct 13, 2026

S-8 REGISTRATION STATEMENT Oct 13, 2026

424B4 PROSPECTUS Oct 9, 2026

EFFECT Oct 8, 2026

S-1MEF REGISTRATION STATEMENT Oct 8, 2026

CERT Oct 8, 2026

8-A12B FOR REGISTRATION OF CERTAIN CLASSES Oct 8, 2026

S-1/A REGISTRATION STATEMENT Oct 7, 2026

S-1/A AMENDMENT NO. 1 TO FORM S-1 Oct 5, 2026

S-1 REGISTRATION STATEMENT Sep 18, 2026

DRS/A Aug 14, 2026

DRS/A Jun 16, 2026

DRS/A May 1, 2026

DRS Feb 17, 2026

D Item 06b May 6, 2025

D/A Item 06b May 15, 2024